US Patent:
20120190666, Jul 26, 2012
Inventors:
Christiane Bode - Somerville MA, US
Alessandro Boezio - Somerville MA, US
Alan C. Cheng - San Francisco CA, US
Deborah Choquette - Medford MA, US
James Robert Coats - Oak Harbor WA, US
Katrina Woodin Copeland - Sudbury MA, US
Hongbing Huang - Lexington MA, US
Daniel La - Brookline MA, US
Richard Thomas Lewis - Framingham MA, US
Hongyu Liao - Thousand Oaks CA, US
Michele Potashman - Cambridge MA, US
John Stellwagen - Beverly MA, US
Shuyan Yi - Cambridge MA, US
Mark H. Norman - Thousand Oaks CA, US
Markian M. Stec - Moorpark CA, US
Emily Anne Peterson - Cambridge MA, US
Russell Graceffa - Hampton NH, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/52
C07D 401/14
A61K 31/506
A61P 35/02
A61K 31/53
C07D 487/04
A61K 31/5377
A61P 35/00
C07D 473/40
C07D 471/04
US Classification:
51421021, 544264, 51426323, 544328, 514256, 544212, 514245, 544236, 514248, 544296, 544117, 5142332
Abstract:
The present invention provides compounds that are PIKK inhibitors, more specifically, mTOR and/or PI3Kα kinase inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of kinases, specifically PI3 kinases, more specifically, mTOR and/or PI3Kα, such as cancer. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.